Listed on GrantGunner. Last checked 3 Sep 2026.
About this grant
The Austrian Life Sciences 2024–2026 call funds Austrian company-led R&D and clinical studies in life sciences. Eligible focus areas are digitalization with health aspects, new drugs and medical devices, and interventional phase I and II clinical studies. Participation along the entire value chain is required; foreign partners may participate depending on the project.
Who can apply
For-profit companies, non-profit organisations, universities, and research organisations based in Austria. Headcount up to 500 employees. VC-backed allowed via opt-in path. TRL 3-7. Prototype required. US-owned IP preferred but not mandatory. 20% match funding required. Consortium optional. Application in English.